The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Psychiatric Neuromodulation Unit (PNU)

Faculty of Medicine / Department of Clinical Sciences, Lund / Section IV / Psychiatry (Lund)

Phone: +46 46 222 06 11

Visiting address: Sölvegatan 19, Lund

Postal address: BMC D11, 221 84 Lund

Psychiatric Neuromodulation Unit (PNU)'s profile in Lund University Research portal

Description

Our research group investigates underlying mechanisms and treatments for depression. The most efficient treatment for severe depression is electroconvulsive therapy (ECT). In collaboration with Danish researchers, we were the first to demonstrate that the generation of new blood vessels and nerve cells in the brain increase after ECT. Others have subsequently shown that all antidepressant (AD) treatments exert these effects, and it is believed that plasticity in neural circuits is crucial for the AD effect. We now conduct a multicenter study where the AD and cognitive effects of ECT are compared to those of ketamine. Ketamine is an analgesic and anaesthetic agent that appears to exert a faster AD effect compared to traditional treatments, and to also be effective in treatment-resistant patients. Other ongoing preclinical and clinical studies aim to increase the increase the understanding of depression, and improve the diagnosis and treatment of our patients.

Staff

E

  • Joakim Ekstrand

    Research project participant

    joakim [dot] ekstrand [at] med [dot] lu [dot] se

J

  • Aki Johanson

    Research project participant

    aki [dot] johanson [at] med [dot] lu [dot] se

M

  • Pouya Movahed Rad

    Research project participant

    pouya [dot] movahed_rad [at] med [dot] lu [dot] se

T